Agilent Technologies, Inc. (A) Análise de ações

Visão geral da empresa

Agilent Technologies, Inc. operates globally as a provider of application-focused solutions within the life sciences, diagnostics, and applied chemical markets, serving a broad range of customers through its specialized portfolio. The enterprise functions within the Healthcare sector, specifically categorized under the Diagnostics & Research industry, positioning it as a critical infrastructure provider for laboratories and research institutions requiring high-precision analytical instruments. The company demonstrates substantial scale with a market capitalization of $33.07B, annual revenue of $7.06B, and an employed workforce of 18,000 individuals. These financial metrics indicate that Agilent holds a significant position in its market, reflecting a large enterprise capable of sustaining extensive operations and research and development initiatives across its three primary business segments. The revenue figure of $7.06B suggests a robust top-line generation typical of established technology firms, while the market cap of $33.07B implies that the market values its future cash flow potential and intellectual property at a premium relative to its current earnings.

Saúde financeira

The company generated a total revenue of $7.06B and reported a net income of $1.29B, while EBITDA reached $1.97B, illustrating the operational earnings before interest, taxes, depreciation, and amortization. The substantial gap between the $7.06B revenue and the $1.29B net income reveals a cost structure where approximately 47.7% of revenue is consumed by operating expenses, taxes, and interest costs, which is characteristic of capital-intensive manufacturing and technology sectors. Agilent produced a free cash flow of $855.88M, indicating strong financial flexibility to fund capital expenditures, reduce debt, or pursue strategic acquisitions without relying heavily on external financing. Regarding profitability metrics, the gross margin stands at 52.3%, indicating high pricing power and efficient manufacturing; the operating margin is 22.9%, reflecting effective control over operating expenses; and the profit margin is 18.3%, which represents the final earnings available to shareholders after all expenses. The balance sheet shows a cash position of $1.76B against total debt of $3.55B, resulting in a debt-to-equity ratio of 51.39, which suggests a moderately leveraged balance sheet where debt usage is significant but supported by substantial cash reserves. Liquidity is supported by a current ratio of 2.07, meaning the company possesses more than double the current assets required to cover its current liabilities, signaling a conservative approach to short-term obligations. Return on equity is 19.9% and return on assets is 8.5%, metrics that reveal management effectiveness in generating value from shareholders' capital and utilizing the total asset base to drive profitability.

Avaliação de valorização

The trailing twelve-month P/E ratio is 25.87, while the forward P/E is projected at 17.76, implying that the market expects earnings growth in the future that would justify a lower multiple relative to current valuation levels. The price-to-book ratio is 4.78, indicating that the market values the company at a significant premium over its net asset value, reflecting intangible assets such as brand strength, patents, and proprietary technology that are not captured on the balance sheet. Alternative valuation metrics include a price-to-sales ratio of 4.68 and an EV/EBITDA of 17.67, which suggest that the company is valued highly relative to its sales volume and operational earnings, typical for high-margin technology firms. The 52-week trading range spans from a low of $96.43 to a high of $160.27, providing a historical context for price volatility and investor sentiment over the past year. The beta value of 1.30 indicates that the stock price tends to be 30% more volatile than the broader market, suggesting higher sensitivity to market fluctuations compared to large-cap peers with lower beta coefficients.

Growth & Income

Revenue growth year-over-year stands at 7.0%, whereas earnings growth year-over-year is -3.6%, indicating that earnings are currently growing at a slower rate than revenue, which may reflect temporary headwinds in operating expenses or margin compression despite top-line expansion. The company pays a dividend yield of 0.9% with a payout ratio of 22.0%, demonstrating a highly sustainable dividend policy given that the payout ratio is well below the 100% threshold and leaves ample room for reinvestment. With a payout ratio of only 22.0%, the company retains the majority of its earnings to fund growth initiatives, R&D, and balance sheet strengthening rather than distributing all profits to shareholders. The overall profile presents a mix of steady revenue expansion and a conservative income strategy, where the slight decline in earnings growth contrasts with positive revenue momentum, while the low dividend yield reflects a focus on capital allocation for future growth rather than high current income distribution.